No. (877) 443-4006. Id. (Knapp, Scott) (Entered: 03/10/2021), Docket(#8) MOTION to Dismiss Plaintiff's Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. 2201. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Id. AIS, BCBSMS, BCBSA, and Advanced Health Systems, Inc. ("AHS") have settled all disputes arising out of, relating to, or concerning the claims and issues asserted by the parties to the legal proceedings in the lawsuit known as Bond Pharmacy d/b/a Advanced Infusion Solutions v. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Advanced Pain . The Agreement's terms and conditions required AIS to submit a claim form that included a charge for home infusion therapy with the corresponding AHS-defined Healthcare Common Procedure Coding System ("HCPCS") procedure codes. The Alaris Pump Module System is an infusion pump used to deliver medications, blood, and blood products into a patient's body in a controlled manner. Physical address: Carr. County of 1st Plaintiff: Wayne - County Where Action Arose: Wayne - County of 1st Defendant: Out of State. A U.S. District Court judge in West Virginia last week denied Medtronic's motion to dismiss the lawsuit brought by John David Brumfield, who claims that the pump in the SynchroMed II device he had implanted in 2012 to treat back pain stopped delivering the pain medication hydromorphone in 2018. Second Amend. February 7, 2022. Cases involving insurance agreements (subrogations, indemnifications, etc. Fed. P. C., New York, NY- 503A Facility, Wingate's Pharmacy and Compounding (see Anderson Holdings Inc.), Nashua, NH- 503A Facility, Wise Pharmacy, (see Joe Wise Pharmacy, Inc.), Littleton, CO- 503A Facility, Woodland Hills Compounding Pharmacy, (see Algunas, Inc.), Woodland Hills, CA- 503A Facility, Wood's Pharmacy, Inc., (dba The Medicine Shoppe), Boones Mill, VA- 503A Facility, Yeung Business Solutions, LLC, (dba Reliant Pharmacy), Southbury, CT- 503A Facility, Zion Clinical Pharmacy, (see Pharmacy Doctors Enterprises), Hallandale Beach, FL- 503A Facility, Zions RX Formulations Services, (see Rx Formulations), Mesa, AZ- 503A Facility, Analytical Research Laboratories, (see ARL Biopharma, Inc.), Oklahoma City, OK, ARL Biopharma, Inc., (dba Analytical Research Laboratories), Oklahoma City, OK, Front Range Laboratories, Inc., Loveland, CO, Medisca Inc., Saint-Laurent, Quebec, Canada, and Plattsburgh, NY, Professional Compounding Centers of America, dba PCCA, Houston, TX, Sichuan Friendly Pharmaceutical Co., Limited, China, Taizhou Xinyou Pharmaceutical & Chemical Co., Limited, Taizhou City, Zhejiang Province, China, An official website of the United States government, : They contend AIS merely delivered the pharmaceutical component to other providers who administered the drug and managed the patient's care. cecl for dummies; can you transfer doordash credits to another account; advanced infusion solutions lawsuit; June 22, 2022 . BOND PHARMACY INC. 623 HIGHLAND COLONY PKWY STE 100. See AIS's Memo. Release of Transcript Restriction set for 10/4/2021. 2:19-CV-02695 | 2019-06-20, U.S. District Courts | Civil Right | Redacted Transcript Deadline set for 8/6/2021. Limbert v. Miss. Signed by District Judge Denise Page Hood. Release of Transcript Restriction set for 10/4/2021. 19 Guaynabo, PR 00966 Phone (787) 783-2245 Fax (787) 523-1178 / (787) 781-8384. Submit your story on our web site for free, for millions to see. This Court dismissed the ERISA claims. La. Click on the case name to see the full text of the citing case. (Entered: 03/04/2021), (#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia. (dba Rxtra Solutions), Southfield, MI- 503A Facility, Beacon Prescriptions (see DCA Inc.), Southington, CT- 503A Facility, Bedford Pharmacy, Inc. (dba Mytilini Enterprises LLC), Bedford, NH- 503A Facility, Bella Pharmaceuticals, Inc., Glenview, IL- 503A Facility - Ceased Compounding Operations, Bellevue Pharmacy Solutions, St Louis, MO- 503A Facility, Belmar Pharmacy, Lakewood, CO- 503A Facility, Belmar Select Outsourcing, (see BSO, LLC), Lakewood, CO- 503B Facility, Best Value Drug, (see Farmville Discount Drug, Inc.), Farmville, NC- 503A Facility, Bhaumik Diversified LLC dba Texas Star Pharmacy, Dallas, TX- 503A Facility, Biomed PA Inc. (dba Soleo Health), Sharon Hill, PA- 503A Facility, Bioscrip Infusion Services, (see HomeChoice Partners, Inc.), Augusta, GA- 503A Facility, Bioscrip Infusion Services, (see InfuScience, Inc.), Chantilly, VA- 503A Facility, BioScrip Pharmacy (NY), Inc., Lake Success, NY- 503A Facility, Blount Discount Pharmacy, Inc., Alcoa, TN- 503A Facility, Blue Ridge Pharmacy and Compounding Center, Raleigh, NC- 503A Facility, BMD Skincare, Inc., Canoga Park, CA- 503A Facility - Out of business, Bond Pharmacy, Inc. (dba Advanced Infusion Solutions), Clinton, MS- 503A Facility, Bond Pharmacy, Inc. (dba Advanced Infusion Solutions), Ridgeland, MS- 503A Facility, Boothwyn Pharmacy LLC, Kennett Square, PA- 503A Facility, Botrosons Pharmaceutical Inc., (dba Tower Pharmacy and Compounding), Mission Viejo, CA- 503A Facility, brandMD Skin Care, (see TSDR Pharmacy, Inc.), Chatsworth, CA- 503A Facility, Brookfield Pharmacy, Brookfield, CT- 503A Facility, Brookfield Medical/Surgical Supply, Inc., Brookfield, CT- 503B Facility, Brookfield Prescription Center, Inc. (dba MD Custom Rx), Brookfield, WI- 503A Facility, Brookhaven Milling Company, Brookhaven, MS, Brown's Compounding Center, Inc., Englewood, CO- 503A Facility - Out of business, BSO LLC (dba Belmar Select Outsourcing), Lakewood, CO- 503B Facility, Buderer Drug Company Inc. Avon, OH- 503A Facility, Buderer Drug Company Inc. Perrysburg, OH- 503A Facility, Buffalo Pharmacies, Inc., East Amherst, NY- 503A Facility, Burklow Pharmacy, Inc., Pace, FL- 503A Facility, California Pharmacy and Compounding Center, Newport Beach, CA- 503A Facility - De-registered as an Outsourcing Facility, California Specialty Pharmacy, Inc., Whittier, CA- 503A Facility, Cantrell Drug Company,Little Rock,AR- 503A Facility - Out of business, Cape Drugs, (see Valgene Incorporated), Annapolis, MD- 503A Facility, Carepoint Healthcare, LLC (dba Carepoint Pharmacy), Schaumburg, IL- 503A Facility, Care Solutions, Inc., Nashville, TN- 503A Facility, Carltons Dunwoody Pharmacy Corp, (dba Concord, Inc.), Dunwoody, GA- 503A Facility, Cascade Specialty Pharmacy, (see Poulsbo Compounding Pharmacy, LLC), Poulsbo, WA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Homewood, AL- 503A Facility, Central Admixture Pharmacy Services, Inc., Phoenix, AZ- 503B Facility, Central Admixture Pharmacy Services, Inc. Irvine, CA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), San Diego, CA- 503B Facility, Central Admixture Pharmacy Services (CAPS), Wallingford, CT- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Chicago, IL- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Harahan, LA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Woburn, MA- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Kansas City, MO- 503A Facility, Central Admixture Pharmacy Services Inc. Valley View, OH- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Allentown, PA- 503B Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Cranberry Township, PA - 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Horsham, PA- 503A Facility, Central Illinois Compounding, Inc. (dba Preckshot Professional Pharmacy), Peoria Heights, IL- 503A Facility, CFP Acquisitions, Inc, Tulsa, OK- 503A Facility, Chastains, Inc., (dba Owl Tri State Pharmacy), Clarkston, WA- 503A Facility, Chen Shwezin, Inc., (dba Park Compounding Pharmacy), Westlake Village, CA- 503A Facility, Cincinnati Specialty Pharmacy LLC, West Chester, OH- 503A Facility, Civic Center Pharmacy, Scottsdale, AZ- 503A Facility, Claremore Compounding Center, Inc., Claremore, OK- 503A Facility, Clark Professional Pharmacy, LLC, Ann Arbor, MI- 503A Facility, Clinical Apothecaries, Medina, OH- 503A Facility, Clinical Specialties Compounding Pharmacy, Augusta, GA- 503A Facility - Out of business, CMC Enterprise Pharmacy, Charlotte, NC- 503A Facility - Out of business, Coastal Meds, LLC., Biloxi, MS- 503A Facility, Coast Quality Pharmacy, LLC, Tampa, FL- 503A Facility, College Pharmacy Incorporated, Colorado Springs, CO- 503A Facility, Colonia Care Pharmacy, Colonia, NJ- 503A Facility, Columbia River Pharmacy, LLC, (dba Malley's Compounding Pharmacy), Richland, WA- 503A Facility, Complete Pharmacy and Medical Solutions, LLC, Miami Lakes, FL- 503A Facility -De-registered as an Outsourcing Facility, Compound Care Pharmacy, Louisville, KY- 503A Facility, Compounded Solutions in Pharmacy LLC, Monroe CT- 503A Facility, Compounding Pharmacies of Louisiana Inc. (dba Professional Arts Pharmacy), Lafayette, LA- 503A Facility, Compound Preferred LLC, Idaho Falls, ID - 503B Facility, Conrad-Marr Drug, (see McAlister Drug Corporation), Yukon, OK- 503A Facility, Conversio Health, (see Integrated Health Concepts Inc.), San Luis Obispo, CA- 503A Facility, Coram Healthcare Corp. of Indiana, Crown Point, IN- 503A Facility - Out of business, Cortez Drugs, (see A Chem Rx, LLC), Brooksville, FL- 503A Facility, Crawford's Professional Drugs, Inc., (dba Diket's Professional Drugs, Inc.), Laurel, MS- 503A Facility, CRC Pharmacy, Roswell, GA- 503A Facility, Creative Compounds, (see Oregon Compounding Centers, Inc.), Wilsonville, OR- 503A Facility, Crosbys Drugs Inc., Columbus, OH- 503A Facility, Crowder's Institutional Pharmacy LLC., dba Crowder's Long-Term Care Pharmacy, Bedford, IN- 503A Facility, CSRX Inc., (dba Rushmore Compounding Pharmacy), Rapid City, SD- 503A Facility, Curexa, (see EHT Pharmacy LLC), Egg Harbor Township, NJ- 503A Facility, Customceutical Compounding, LLC, Phoenix, AZ- 503A Facility, Custom Compounding Center, Little Rock, AR- 503A Facility, Custom Compounding Centers, LLC, Los Alamitos, CA- 503A Facility, Custom Meds Inc. Inverness, FL- 503A Facility, Custom RX LLC, Wichita, KS- 503A Facility, Custom RX LLC (dba Custom RX Compounding Pharmacy), Richfield, MN- 503A Facility, D&D Pharma,LLC (dba MedScript Compounding Pharmacy), Noblesville, IN- 503A Facility, D&S Enterprises, LLC (dba Millers Health Mart Pharmacy), Vero Beach, FL- 503A Facility, Davis City Pharmacy, Inc., Weatherford, TX, DCA Inc. (dba Beacon Prescriptions), Southington, CT- 503A Facility, Delta Pharma, Inc., Ripley, MS- 503B Facility, Denson's Specialty Pharmacy, (see Wellcare Rx Investments LLC), Wheaton, IL- 503A Facility, Denver Solutions, LLC (dba Leiter's Health), Englewood, CO- 503B Facility, Designer Drugs, (see The Wellness Center Pharmacy, Inc.), Chattanooga, TN- 503A Facility, Diabetes Corporation of America, Franklin, TN- 503A Facility, Diamond Drugs, Inc., (dba Diamond Pharmacy Services), Indiana, PA- 503A Facility, Diamond Pharmacy, LLC, Houston, TX- 503A Facility, Dignity Health- Northridge Hospital Medical Center, Northridge, CA- 503A Facility, Diket's Professional Drugs, Inc., (see Crawford's Professional Drugs, Inc.), Laurel, MS- 503A Facility, Diplomat Pharmacy, Inc. (dba Diplomat Specialty Pharmacy), Flint, MI- 503A Facility, Diversified Pharmacy Inc., (dba University Compounding Pharmacy), Troy, MI- 503A Facility, DNA Pharmacy Services, Inc. (dba Palm Beach Compounding), Jupiter, FL- 503A Facility - Ceased sterile compounding, Dorneyville Pharmacy, Allentown, PA- 503A Facility, Dougherty's Pharmacy, Dallas, TX- 503A Facility, Downing Labs, LLC, (formerly NuVision Pharmacy), Dallas, TX- 503A Facility - Out of business, D.R. A valid claim for relief contains "sufficient factual matter, accepted as true," giving the claim "facial plausibility" and allowing "the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Leagle.com reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions. Docket alerts are an advanced feature of CourtListener. Use the links below to access additional information about this case on the US Court's PACER system. Get a Demo Casetext research Parallel Search Compose AllSearch Pricing Blog Mailing Address: PMB 507 1353 Rd. It is located at 18451 Dallas Pkwy, Ste 125, Dallas, Texas 75287. in Support of Mot. Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), Docket(#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Motion Hearing set for 6/9/2021 02:30 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 04/21/2021), (#19) NOTICE of Appearance by Rian Cierra Dawson on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) [21-30534] REVIEWED AND/OR EDITED - The original text prior to review appeared as follows: UNOPPOSED MOTION filed by Appellant Mr. Randy Denning to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. Pharmacy, Inc., Midland, TX- 503A Facility, Drug Crafters, L.P., Frisco, TX- 503A Facility, Drug Depot Inc. (dba APS Pharmacy), Palm Harbor, FL- 503A Facility, Drugs are Us, Inc. (dba Hopewell Pharmacy), Hopewell, NJ- 503A Facility, Duren's Health Mart Pharmacy, Waynesboro, TN- 503A Facility - Ceased Compounding Operations, Dynalabs LLC, Saint Louis, MO- 503A Facility, Eagle New York, Garfield, NJ- 503A Facility, Eagle Pharmacy, Inc., Hoover, AL- 503B Facility, East Marietta Drug Company, Marietta, GA- 503A Facility, Eastern Pharmacy, Inc., Ocala, FL- 503A Facility, Eastern States Compounding Pharmacy,(see Northern New England Compounding Pharmacy), Littleton, NH- 503A Facility, Edge Pharmacy Services, LLC, Colchester, VT- 503B Facility, EHT Pharmacy LLC, (dba Curexa), Egg Harbor Township, NJ- 503A Facility, Elkhart Pharmacy, Elkhart, TX- 503A Facility - Out of business, Empower Clinic Services, LLC, Houston, TX- 503B Facility, Enclara Pharmacia Inc., Sharon Hill, PA- 503A Facility - Ceased sterile compounding, Essential Pharmacy Compounding, Omaha, NE- 503A Facility, Essential Wellness Pharma, (see Kalman Health & Wellness Inc.), Peoria, IL- 503A Facility, Everwell Specialty Pharmacy, Pensacola, FL (see Pensacola Apothecary Inc.)- 503A Facility, Exela Pharma Sciences, LLC, Lenoir, NC- 503B Facility, Expert Compounding Pharmacy, Lake Balboa, CA - 503A Facility, Fagron Compounding Services LLC (dba Fagron Sterile Services), Wichita, KS- 503B Facility, Fairview Compounding Pharmacy, Minneapolis, MN- 503A Facility, Fallon Wellness Pharmacy, LLC, Latham, NY- 503A Facility, Family Pharmacy of Statesville, Inc., Statesville, NC- 503A Facility, Far Hills Pharmacy, (see Pharmaview, Inc.), Bedminster, NJ- 503A Facility, Farmacia Le Salud Inc., Caguas, PR- 503A Facility, Farmakeio Outsourcing LLC, Southlake, TX- 503B Facility, Farmville Discount Drug, Inc., (dba Best Value Drug), Farmville, NC- 503A Facility - Out of business, FH Investments Inc., (dba Asteria Health), Birmingham, AL- 503B Facility, First Call IV Pharmacy, LLC, Kenner, LA- 503A Facility, First Pharma Associates LLC (dba Riverpoint Pharmacy), Spokane, WA- 503A Facility, First Royal Care Co. LLC, (dba Red Mountain Compounding Pharmacy), Mesa, AZ- 503A Facility, Flourish Integrative Pharmacy, LLC, Oklahoma City, OK- 503A Facility, Foothills Professional Pharmacy, Ltd., Phoenix, AZ- 503A Facility, Foundation Care LLC, Earth City, MO- 503A Facility, Franck's Compounding Lab (see Franck's Lab, Inc.), Ocala, FL- 503A Facility - Out of business, Franck's Lab, Inc.(dba Franck's Compounding Lab), Ocala, FL- 503A Facility - Out of business, Franck's Lab, Inc.(dba Trinity Care Solutions), Ocala, FL- 503A Facility - Out of business, Freedom Fertility Pharmacy, (see Lynnfield Drug, Inc.), Byfield, MA- 503A Facility, Freedom Pharmacy,(see HHCS Pharmacy, Inc.), Orlando, FL- 503A Facility, Fresenius Kabi Compounding, LLC, Canton, MA- 503B Facility, Front Door Pharmacy, LLC, (dba Pure Pharmacy), Houston, TX- 503A Facility, Front Range Laboratories, Incorporated, Loveland, CO- 503A Facility, Fusion IV Pharmaceuticals Inc. (dba Axia Pharmaceuticals), Los Angeles, CA- 503A Facility - De-registered as an Outsourcing Facility, FVS Holdings, Inc. (dba Green Valley Drugs), Henderson, NV- 503A Facility - Out of business, Garda Rx LLC., Apollo, PA- 503A Facility, Geneva Woods Pharmacy, Anchorage, AK- 503A Facility, Gipsco Investment Corp. (dba Lee Silsby Compounding Pharmacy), Cleveland Heights, OH- 503A Facility, Glades Drugs, Pahokee, FL- 503A Facility, Good Day Pharmacy, (see Professional Pharmacy Services, Inc.), Loveland, CO- 503A Facility, Good Health Inc., (dba Premier Pharmacy Services), Baldwin Park, CA- 503A Facility, Grandpa's Compounding Pharmacy, Inc. Placerville, CA- 503A Facility - Out of business, Green Hills Health and Wellness Pharmacy, Inc. (dba Health and Wellness Compounding Pharmacy),Nashville, TN- 503A Facility, Greenpark Compounding Pharmacy, (see Prescription Labs, Inc.), Houston, TX- 503A Facility, Green Valley Drugs,(see FVS Holdings, Inc.), Henderson, NV- 503A Facility, Guardian Pharmacy Services, Dallas, TX- 503A Facility - Out of business, Hallandale Pharmacy, (see Pharmcore Inc.), Hallandale, FL- 503A Facility, Hallettsville Pharmacy, LLC, Hallettsville, TX- 503A Facility, Hartley Medical Center Pharmacy, Inc., Long Beach, CA- 503A Facility, Hawaii Health Systems Corporation, (dba Kona Community Hospital Pharmacy), Kealakekua, HI- 503A Facility, Hazle Compounding, LLC, Hazelton, PA, 503A, Healix Infusion Therapy, Inc., Sugar Land, TX- 503A Facility - De-registered as an Outsourcing Facility, Health and Wellness Compounding Pharmacy,(see Green Hills Health and Wellness Pharmacy, Inc.), Nashville, TN- 503A Facility, Health Dimensions, Inc., Farmington Hills, MI- 503A Facility, Health Innovations Pharmacy, Inc., Southern Pines, NC- 503A Facility, The Healthy Choice Apothecary (see Jacobs Pills Inc.), Elmsford, NY- 503A Facility, Healthy Choice Compounding LLC, Elmsford, NY 483- 503A Facility, Heartland Home Infusions, Inc. (dba HHI Infusion Services), Burr Ridge, IL- 503A Facility, Heartland I.V. See Order [61]. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Attorney at Sheppard Mullin Richter & Hampton, LLP, Attorney at Sheppard, Mullin, Richter & Hampton LLp, Attorney at Sheppard Mullin Richter and Hampton, LLP, Attorney at Sheppard Mullin Richter & Hampton LLP, Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez, Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, Docket(#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. Text Size:thredup ambassador program how to dress more masculine for a woman. And the best part of all, documents in their CrowdSourced Library are FREE! . Removed To Federal Court Counsel at Phelps Dunbar and Sheppard, Mullin, Richter & Hampton on Friday removed a breach-of-contract class action lawsuit against Bond Pharmacy, Advanced Infusion. [21-30534] (DDL) [Entered: 09/17/2021 02:02 PM], ELECTRONIC RECORD ON APPEAL FILED. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017.